Table 2

Most frequently mentioned themes concerning the benefits, drawbacks, and obstacles to collaboration on product listing agreements
Number of policy makers that mentioned theme(n = 9)
  Increased bargaining power 7
  Provincial equity in price 5
  Provincial equity in access 5
  Administrative efficiency 2
  Increased access, can fund more drugs 1
  Delay/length of process 5
  Reduction in provincial autonomy 4
  Savings may be lost for large provinces 2
  Resource-intensive 2
  Decreased access in some jurisdictions 1
  Differences in policy institutions 6
  Provincial and/or federal will 6
  Differences structure of drug benefit programs 5
  Technical and administrative resources 5
  Political acceptability of the decision 4

Morgan et al.

Morgan et al. BMC Health Services Research 2013 13:34   doi:10.1186/1472-6963-13-34

Open Data